LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2020ACC: 0001209191-20-049093
Officer· Chief Financial Officer
Since Jun 2018
+174.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
174.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+87.00
Price / share
$13.73
Trade value
$1.19K
% of position
3.0%
8/31/2020
2.89K→2.97K
Total
Net shares
+87.00
Net value
$1.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2020 | A · Award | +87.00 | $13.73 | $1.19K | 3.0% | 2.89K | 2.97K |
| Total | +87.00 | $1.19K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
87.00 shares
Shares
+87.00
Strike price
16.15
Held after
87.00
Exercisable
—
8/31/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock87.00 shares | 8/31/2020 | A · Award | +87.00 | 16.15 | — | 87.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.13M
Total
15.13M indirect15.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.13M | Indirect |
| Total | 15.13M | 15.13M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported